About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 195 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 195 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 195 trials

CompletedA Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With SchizophreniaThe primary objective of this study is to evaluate the efficacy of TV-44749 in adult participants with schizophrenia.NCT05693935·Bentonville, Arkansas and 81 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy to Evaluate the Efficacy and Safety of GSK239512 in SchizophreniaThis study aims to evaluate the cognitive enhancing effects and tolerability of GSK239512 compared to placebo in patients with schizophreniaNCT01009060·Garden Grove, California and 14 others

CompletedCATIE- Schizophrenia TrialThe CATIE Schizophrenia Trial is part of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project.NCT00014001·Chula Vista, California and 53 others

CompletedSafety and Cognitive Function Study of EVP-6124 in Patients With SchizophreniaThis study is being conducted to determine the safety and effect on cognitive function of two different doses of an investigational medication, EVP-6124, in individuals with…NCT00968851·Glendale, California and 30 others

CompletedA Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaThis is a safety and efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.NCT01655680·Anaheim, California and 60 others

RecruitingRelapse Prevention Trial Evaluating KarXT Treatment in SchizophreniaThe purpose of the study is to evaluate the relapse prevention of KarXT in the treatment of participants with SchizophreniaNCT07686263·Bentonville, Arkansas and 58 others

CompletedEfficacy and Safety Study for Cognitive Deficits in Adult Subjects With SchizophreniaThis is an efficacy and safety study evaluating an experimental treatment for cognitive deficits in adults with schizophrenia.NCT01077700·Anaheim, California and 23 others

CompletedA Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With SchizophreniaThis study will evaluate the safety and tolerability of aripiprazole lauroxil (also known as ARISTADA, ALKS 9070).NCT02634320·Little Rock, Arkansas and 17 others

TerminatedA Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With SchizophreniaThe primary purpose of this study is to assess the long-term safety and tolerability of oral emraclidine in adult participants with schizophrenia.NCT05443724·Phoenix, Arizona and 84 others

Not yet recruitingCognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2In Study 2, investigators will recruit individuals with schizophrenia (SZ) and or schizoaffective disorder (SZA) and healthy controls (HC) using optimized behavioral tasks to…NCT07875790·Irvine, California and 4 others

CompletedThe Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I DisorderOlanzapine is currently marketed for the treatment of schizophrenia and acute manic episodes with bipolar 1 disorder.NCT00044187·El Centro, California and 15 others

CompletedA Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)This study will evaluate weight gain of ALKS 3831 compared to olanzapine in adult subjects with schizophrenia.NCT02694328·Little Rock, Arkansas and 53 others

CompletedStudy of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyThe purpose of this study is to determine if EVP-6124 (an alpha-7 nAChR agonist) enhances the cognitive abilities of subjects with Schizophrenia who are also taking stable…NCT01714661·Tucson, Arizona and 93 others

CompletedA 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyThis study is being conducted to further investigate the safety of prolonged exposure to EVP-6124 in subjects with Schizophrenia receiving a stable dose of an atypical…NCT01714713·Little Rock, Arkansas and 127 others

CompletedOpen-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral AripiprazoleThe purpose of this study is to determine the usability of the Medical Information Device #1 (MIND1) system in adults with schizophrenia who are treated with oral aripiprazole.NCT02219009·Cerritos, California and 5 others

CompletedA Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaThe primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 3831 in subjects with schizophrenia.NCT02873208·Little Rock, Arkansas and 44 others

CompletedEfficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative SymptomsTo explore the efficacy of SPD489, as adjunctive therapy to a stable dose of atypical antipsychotic medication, on negative symptoms in adult subjects with clinically stable…NCT00922272·Little Rock, Arkansas and 26 others

CompletedA Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With SchizophreniaThe purpose of this study is to evaluate the efficacy of paliperidone palmitate 3 month formulation (PP3M) compared with placebo in delay of the time to first occurrence of…NCT01529515·Little Rock, Arkansas and 52 others

CompletedTreatment of Social Cognition in Schizophrenia TrialThis study is a multi-site, prospective, parallel arm, double-blind, randomized, controlled clinical trial to assess the efficacy of an experimental software program targeting…NCT02246426·Los Angeles, California and 3 others

RecruitingA Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With SchizophreniaThis is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of 3 different dose…NCT07191483·Little Rock, Arkansas and 14 others

PreviousPage 5 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia